My Quote Request
No products added yet
6505-01-103-1276
20 Products
TEARS PLUS
LUBRICANT,OPHTHALMIC
NSN, MFG P/N
6505011031276
NSN
6505-01-103-1276
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.400 PERCENTAGE, W/V POLYVINYL ALCOHOL ACTIVE INGREDIENT AND 0.600 PERCENTAGE, W/V POVIDONE ACTIVE INGREDIENT
ADMINISTRATION: OPHTHALMIC
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: CONTAINS CHLOROBUTANOL 0.5% AS A PRESERVATIVE AND SODIUM CHLORIDE; UNBUFFERED
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00182-0538-05
ERYTHROMYCIN STEARATE TABLETS,USP
NSN, MFG P/N
6505011028663
NSN
6505-01-102-8663
NDC00182-0538-05
ERYTHROMYCIN STEARATE TABLETS,USP
NSN, MFG P/N
6505011028663
NSN
6505-01-102-8663
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ERYTHROMYCIN STEARATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:NONENTERIC FILM
Related Searches:
NDC00641-2470-45
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505011028665
NSN
6505-01-102-8665
NDC00641-2470-45
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505011028665
NSN
6505-01-102-8665
MFG
ELKINS-SINN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10000.000 UNITS HEPARIN SODIUM PER MILLILITER
ADMINISTRATION: INTRAVENOUS OR SUBCUTANEOUS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00182-0532-10
DISULFIRAM TABLETS,USP
NSN, MFG P/N
6505011029409
NSN
6505-01-102-9409
NDC00182-0532-10
DISULFIRAM TABLETS,USP
NSN, MFG P/N
6505011029409
NSN
6505-01-102-9409
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS DISULFIRAM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
FREAMINE III
AMINO ACID INJECTION
NSN, MFG P/N
6505011029411
NSN
6505-01-102-9411
MFG
B. BRAUN MEDICAL INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.500 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACID INJECTION 50ML BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: A NON-PYROGENIC,HYPERTONIC SOLUTION OF AMINO ACID INJECTION,WITHOUT ADDED ELECTROLYATES,FOR INTRAVENOUS ADMINISTRATION; CONTAINS TRACES OF ELECTROLYTES NATURALLY OCCURING IN AMINO ACIDS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00264-1903-10
AMINO ACID INJECTION
NSN, MFG P/N
6505011029411
NSN
6505-01-102-9411
NDC00264-1903-10
AMINO ACID INJECTION
NSN, MFG P/N
6505011029411
NSN
6505-01-102-9411
MFG
B. BRAUN MEDICAL INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.500 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACID INJECTION 50ML BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: A NON-PYROGENIC,HYPERTONIC SOLUTION OF AMINO ACID INJECTION,WITHOUT ADDED ELECTROLYATES,FOR INTRAVENOUS ADMINISTRATION; CONTAINS TRACES OF ELECTROLYTES NATURALLY OCCURING IN AMINO ACIDS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC0074-1088-03
AMINO ACID INJECTION
NSN, MFG P/N
6505011029411
NSN
6505-01-102-9411
MFG
ABBOTT LABORATORIES INC ROSS PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.500 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACID INJECTION 50ML BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: A NON-PYROGENIC,HYPERTONIC SOLUTION OF AMINO ACID INJECTION,WITHOUT ADDED ELECTROLYATES,FOR INTRAVENOUS ADMINISTRATION; CONTAINS TRACES OF ELECTROLYTES NATURALLY OCCURING IN AMINO ACIDS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
S9031
AMINO ACID INJECTION
NSN, MFG P/N
6505011029411
NSN
6505-01-102-9411
MFG
B. BRAUN MEDICAL INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.500 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINO ACID INJECTION 50ML BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: A NON-PYROGENIC,HYPERTONIC SOLUTION OF AMINO ACID INJECTION,WITHOUT ADDED ELECTROLYATES,FOR INTRAVENOUS ADMINISTRATION; CONTAINS TRACES OF ELECTROLYTES NATURALLY OCCURING IN AMINO ACIDS
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
K-TAB
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011030211
NSN
6505-01-103-0211
K-TAB
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011030211
NSN
6505-01-103-0211
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 750MG 1000S
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WAX MATRIX
THERAPEUTIC EQUIVALENT: K-TAB BY ABBOTT LABS. PHARM. PRODS. DIV.
Related Searches:
NDC00074-7804-19
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011030211
NSN
6505-01-103-0211
NDC00074-7804-19
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS,USP
NSN, MFG P/N
6505011030211
NSN
6505-01-103-0211
MFG
ABBOTT LABORATORIES INC ROSS PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 750MG 1000S
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: WAX MATRIX
THERAPEUTIC EQUIVALENT: K-TAB BY ABBOTT LABS. PHARM. PRODS. DIV.
Related Searches:
25-638-4
FERROUS FUMARATE,DOCUSATE SODIUM,AND MULTIVITAMIN TABLETS
NSN, MFG P/N
6505011031215
NSN
6505-01-103-1215
25-638-4
FERROUS FUMARATE,DOCUSATE SODIUM,AND MULTIVITAMIN TABLETS
NSN, MFG P/N
6505011031215
NSN
6505-01-103-1215
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 10.000 MILLIGRAMS CALCIUM PANTOTHENATE ACTIVE INGREDIENT AND 25.000 MICROGRAMS CYANOCOBALAMIN ACTIVE INGREDIENT AND 30.000 USP UNITS DL-ALPHA-TOCOPHERYL ACETATE ACTIVE INGREDIENT AND 50.000 MILLIGRAMS
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
~1: DIOCTYL SODIUM SULFOSUCCINATE ACTIVE INGREDIENT AND 1.000 MILLIGRAMS FOLIC ACID ACTIVE INGREDIENT AND 304.200 MILLIGRAMS FERROUS FUMARATE ACTIVE INGREDIENT AND 30.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 5.000 MILLIGRAMS PYRIDOXINE ACTIVE
~2: INGREDIENT AND 6.000 MILLIGRAMS RIBOFLAVIN ACTIVE INGREDIENT AND 6.000 MILLIGRAMS THIAMINE MONONITRATE ACTIVE INGREDIENT
Related Searches:
NDC00071-0638-24
FERROUS FUMARATE,DOCUSATE SODIUM,AND MULTIVITAMIN TABLETS
NSN, MFG P/N
6505011031215
NSN
6505-01-103-1215
NDC00071-0638-24
FERROUS FUMARATE,DOCUSATE SODIUM,AND MULTIVITAMIN TABLETS
NSN, MFG P/N
6505011031215
NSN
6505-01-103-1215
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 10.000 MILLIGRAMS CALCIUM PANTOTHENATE ACTIVE INGREDIENT AND 25.000 MICROGRAMS CYANOCOBALAMIN ACTIVE INGREDIENT AND 30.000 USP UNITS DL-ALPHA-TOCOPHERYL ACETATE ACTIVE INGREDIENT AND 50.000 MILLIGRAMS
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
~1: DIOCTYL SODIUM SULFOSUCCINATE ACTIVE INGREDIENT AND 1.000 MILLIGRAMS FOLIC ACID ACTIVE INGREDIENT AND 304.200 MILLIGRAMS FERROUS FUMARATE ACTIVE INGREDIENT AND 30.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 5.000 MILLIGRAMS PYRIDOXINE ACTIVE
~2: INGREDIENT AND 6.000 MILLIGRAMS RIBOFLAVIN ACTIVE INGREDIENT AND 6.000 MILLIGRAMS THIAMINE MONONITRATE ACTIVE INGREDIENT
Related Searches:
P-D 638
FERROUS FUMARATE,DOCUSATE SODIUM,AND MULTIVITAMIN TABLETS
NSN, MFG P/N
6505011031215
NSN
6505-01-103-1215
P-D 638
FERROUS FUMARATE,DOCUSATE SODIUM,AND MULTIVITAMIN TABLETS
NSN, MFG P/N
6505011031215
NSN
6505-01-103-1215
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 10.000 MILLIGRAMS CALCIUM PANTOTHENATE ACTIVE INGREDIENT AND 25.000 MICROGRAMS CYANOCOBALAMIN ACTIVE INGREDIENT AND 30.000 USP UNITS DL-ALPHA-TOCOPHERYL ACETATE ACTIVE INGREDIENT AND 50.000 MILLIGRAMS
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
~1: DIOCTYL SODIUM SULFOSUCCINATE ACTIVE INGREDIENT AND 1.000 MILLIGRAMS FOLIC ACID ACTIVE INGREDIENT AND 304.200 MILLIGRAMS FERROUS FUMARATE ACTIVE INGREDIENT AND 30.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 5.000 MILLIGRAMS PYRIDOXINE ACTIVE
~2: INGREDIENT AND 6.000 MILLIGRAMS RIBOFLAVIN ACTIVE INGREDIENT AND 6.000 MILLIGRAMS THIAMINE MONONITRATE ACTIVE INGREDIENT
Related Searches:
TABRON FILMSEALS
FERROUS FUMARATE,DOCUSATE SODIUM,AND MULTIVITAMIN TABLETS
NSN, MFG P/N
6505011031215
NSN
6505-01-103-1215
TABRON FILMSEALS
FERROUS FUMARATE,DOCUSATE SODIUM,AND MULTIVITAMIN TABLETS
NSN, MFG P/N
6505011031215
NSN
6505-01-103-1215
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 10.000 MILLIGRAMS CALCIUM PANTOTHENATE ACTIVE INGREDIENT AND 25.000 MICROGRAMS CYANOCOBALAMIN ACTIVE INGREDIENT AND 30.000 USP UNITS DL-ALPHA-TOCOPHERYL ACETATE ACTIVE INGREDIENT AND 50.000 MILLIGRAMS
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
~1: DIOCTYL SODIUM SULFOSUCCINATE ACTIVE INGREDIENT AND 1.000 MILLIGRAMS FOLIC ACID ACTIVE INGREDIENT AND 304.200 MILLIGRAMS FERROUS FUMARATE ACTIVE INGREDIENT AND 30.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 5.000 MILLIGRAMS PYRIDOXINE ACTIVE
~2: INGREDIENT AND 6.000 MILLIGRAMS RIBOFLAVIN ACTIVE INGREDIENT AND 6.000 MILLIGRAMS THIAMINE MONONITRATE ACTIVE INGREDIENT
Related Searches:
750
BISACODYL SUSPENSION
NSN, MFG P/N
6505011031217
NSN
6505-01-103-1217
MFG
FLEET COMPANY INCORPORATED C. B. DBA FLEET
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.333 MILLIGRAMS BISACODYL PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 37.500 MILLILITERS OR 1.250 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: WITH PRELUBRICATED RECTAL TIP
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
BIS100
BISACODYL SUSPENSION
NSN, MFG P/N
6505011031217
NSN
6505-01-103-1217
MFG
IDIS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.333 MILLIGRAMS BISACODYL PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 37.500 MILLILITERS OR 1.250 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: WITH PRELUBRICATED RECTAL TIP
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
FLEET BISACODYL ENEMA
BISACODYL SUSPENSION
NSN, MFG P/N
6505011031217
NSN
6505-01-103-1217
FLEET BISACODYL ENEMA
BISACODYL SUSPENSION
NSN, MFG P/N
6505011031217
NSN
6505-01-103-1217
MFG
FLEET COMPANY INCORPORATED C. B. DBA FLEET
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.333 MILLIGRAMS BISACODYL PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 37.500 MILLILITERS OR 1.250 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: WITH PRELUBRICATED RECTAL TIP
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
NDC00132-0703-36
BISACODYL SUSPENSION
NSN, MFG P/N
6505011031217
NSN
6505-01-103-1217
NDC00132-0703-36
BISACODYL SUSPENSION
NSN, MFG P/N
6505011031217
NSN
6505-01-103-1217
MFG
FLEET COMPANY INCORPORATED C. B. DBA FLEET
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.333 MILLIGRAMS BISACODYL PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 37.500 MILLILITERS OR 1.250 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC SQUEEZE
SPECIAL FEATURES: WITH PRELUBRICATED RECTAL TIP
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
0165
LUBRICANT,OPHTHALMIC
NSN, MFG P/N
6505011031276
NSN
6505-01-103-1276
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.400 PERCENTAGE, W/V POLYVINYL ALCOHOL ACTIVE INGREDIENT AND 0.600 PERCENTAGE, W/V POVIDONE ACTIVE INGREDIENT
ADMINISTRATION: OPHTHALMIC
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: CONTAINS CHLOROBUTANOL 0.5% AS A PRESERVATIVE AND SODIUM CHLORIDE; UNBUFFERED
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC11980-165-40
LUBRICANT,OPHTHALMIC
NSN, MFG P/N
6505011031276
NSN
6505-01-103-1276
MFG
ALLERGAN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.400 PERCENTAGE, W/V POLYVINYL ALCOHOL ACTIVE INGREDIENT AND 0.600 PERCENTAGE, W/V POVIDONE ACTIVE INGREDIENT
ADMINISTRATION: OPHTHALMIC
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: CONTAINS CHLOROBUTANOL 0.5% AS A PRESERVATIVE AND SODIUM CHLORIDE; UNBUFFERED
TOTAL PRIMARY CONTAINER QUANTITY: 6
